More Galleries
7 lifehacks to eliminate your holiday hassle Whether curating the perfect gift or finding a pet-sitter, these startups offer time-saving services that might just seem like holiday magic. More
San Francisco: The best city to make things From electric motorcycles to death shrouds, San Francisco's manufacturing sector is booming. More
6 designers shaking up fashion These designers are changing the way we dress, accessorize and shop, from custom made-to-fit dresses to smart jewelry that's actually stylish. More
Special Offer
2 of 8
BACK NEXT
Affinergy Inc.
Affinergy Inc.
Technology: Interfacial biomaterials
Location: Durham, N.C.
Grant: $3 million (March 2008)
From: National Institute of Health
Employees: 32

Affinergy Inc. develops interfacial biomaterials, which CEO Peyton Anderson likens to glue or two-sided tape. But instead of sticking crayon drawings to the wall, the startup's peptide technology helps drugs hold on to implanted medical devices, potentially reducing health complications. For example, attaching antibodies to a hip replacement could stave off infections, which are sometime fatal. "We can have a direct and large impact on patients," Anderson says. "These are real people with real problems."

Affinergy's story goes back to Duke University when its founders, then a chemist and a biologist at the school, collaborated on an academic project that produced biological linking molecules able to stick medicine to metal, plastic, or even Teflon. The five-year-old company received the first of its 12 SBIR grants in 2005, and to date has earned a total of $5.3 million from the National Institute of Health. The government awards have paid for research and development to demonstrate that the idea works, which fueled interest by prospective partners. The money also empowered Affinergy to develop its science for devices in multiple areas - from cardiology to general surgery.

Affinergy has also organized $5 million in outside funding, including about a $1 million from a small venture-capital firm, and an undisclosed amount from its partners, which include chemical giant DuPont. Products are still three to five years away from reaching market. - Herman Wong

NEXT: NovaShield Inc.

Last updated April 11 2008: 4:34 PM ET

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.